Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001615774-18-000388

Executive Chairman disposed of 172,803 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WEIL A LORNE Executive Chairman 2018-01-15 Other disposition −40,645 266,900 D: show line 1 in the form
WEIL A LORNE Executive Chairman 2018-01-15 Other disposition −132,158 867,842 I: show line 2 in the form
Loading xslF345X03/s108741_form4.xml…